The fate of  3 H-norepinephrine released from isolated atria and vas deferens: effect of field stimulation.
D000319:Adrenergic beta-Antagonists / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D016275:Atrial Function; D002118:Calcium / Q000494:pharmacology; D002845:Chromatography; D004558:Electric Stimulation; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D014316:Tritium; D014649:Vas Deferens / Q000187:drug effects / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D009647:Normetanephrine; D014316:Tritium; D010293:Pargyline; D008274:Magnesium; D002118:Calcium; D009638:Norepinephrine